IFC Health Newsletter | May 2021
d9cb459d-0e6d-40de-9411-ecbf4b371b6f_div
*|MC:SUBJECT|*
*|MC_PREVIEW_TEXT|*
What has IFC done over the past year to strengthen healthcare systems in emerging markets amidst the pandemic and what are some new plans being developed? Elena Sterlin discusses this in a piece for Healthcare Markets International.
How can we bring more advanced medical equipment to Africa? IFC’s Mary-Jean Moyo and Manuel Reyes-Retana, in this blog for CNBC Africa, explain how IFC’s new program will help bridge financing gaps between healthcare business and suppliers.
How do pharmaceutical manufacturers in emerging markets offer local consumers affordable, accessible generic medicines and healthcare products tailored to their needs? Read more about it in this IFC special feature story. In a related piece, IFC’s Dr. Subir Basak writes in pharmaphorum about how local pharmaceutical manufacturers can successfully scale up and tap larger markets.
And finally, in this IFC feature piece, we look at the Egyptian health tech start-ups that are disrupting the medical system and changing how people in Egypt access care.
Also take a look at our case study series: In our newest study, we profile Nyaho Medical Centre, a Ghana based medical provider that is taking innovative steps in its operations, demonstrating what a private healthcare provider can do to create a central position for itself and a reputation for excellence and innovation.
|
|
|
|
AMEF | Africa
The $300 million African Medical Equipment Facility is an IFC-led partnership that connects major equipment manufacturers like Philips to financial institutions across several Africa countries to help smaller healthcare businesses access medical equipment.
|
|
|
A $40 million IFC loan to Glenmark Pharmaceuticals, a manufacturer in India that produces generic drugs and active pharmaceutical ingredients, will help the company make more affordable, high quality medicines.
|
|
|
Neolpharma | Mexico
Cardiology, oncology, and diabetes are some of the fields Mexican pharmaceutical group Neolpharma specializes in. A $30 million IFC financing package will help to increase access to high-quality, affordable medicines in the Latin America and Caribbean region.
|
|
|
|
|